Press Releases

07.11.2019 | Nanion and Assay.Works Partner to offer Drug Discovery Services for Membrane Transporter Targets

Munich, Germany, November 7th 2019: Nanion Technologies, a leading provider of automated electrophysiology systems, today announced its partnership with Assay.Works, experts in assay development and High Throughput Screening (HTS), who will be providing SURFE²R 96SE assays “As-a-Service” for membrane transporter research.
Membrane transport proteins, enabling active and secondary active transport of ions and solutes across the membrane, are important drug targets but may also be involved in unwanted side effects of novel drug candidates. As response to the growing demand in assay options for membrane transporters and to afford researchers access to SSM-based electrophysiology, Nanion and Assay.Works have entered into a partnership.

Read the full press release here.

Back

 

New Genedata Screener®APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.